NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve hyperosmolar agents for patients with malignant stroke an. After hearing and assimilating this program, the clinician will be better able to:
1. Explain the Monro-Kellie doctrine and its importance in malignant stroke.
2. List treatment options in malignant stroke.
3. Administer mannitol in treatment of malignant stroke.
4. Use monoclonal antibodies in patients who have failed multiple preventive medicines.
5. Administer atogepant in patients with episodic migraine.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Neurology
- Start Date: 2022-11-05 05:00:00
- End Date: 2022-11-05 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all